Cargando…
Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery
Self-assembling prodrugs represents a robust and effective nanotherapeutic approach for delivering poorly soluble anticancer drugs. With numerous intrinsic advantages, self-assembling prodrugs possess the maximum drug loading capacity, controlled drug release kinetics, prolonged blood circulation, a...
Autores principales: | Wang, Zhiren, Chen, Jiawei, Little, Nicholas, Lu, Jianqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Acta Materialia Inc. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245299/ https://www.ncbi.nlm.nih.gov/pubmed/32454086 http://dx.doi.org/10.1016/j.actbio.2020.05.026 |
Ejemplares similares
-
Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer
por: Han, Weidong, et al.
Publicado: (2019) -
Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
por: Lee, Na-Hyun, et al.
Publicado: (2022) -
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023) -
Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy
por: Chen, Xiaona, et al.
Publicado: (2021) -
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery
por: Baroud, Milad, et al.
Publicado: (2021)